scanrail / iStockphoto.com
Since joining Eli Lilly’s patent division nearly 20 years ago, Manisha Desai has worked on the procurement and enforcement of patents worldwide.
Although she has focused exclusively on patent litigation for the past ten years, Manisha Desai stays in touch with patent procurement through remaining active in various IP policy matters, as LSIPR reports.
“The best parts of the job are also some of the greatest challenges,” Desai explains. “I love working with our affiliates and local counsel, especially in the emerging markets, as I can learn so much from them about local laws and procedures,” she adds, saying that she has managed patent litigation in Latin America, Russia, the Middle East, and South Asia, as well as across the US.
However, in emerging markets, expectations have to be managed when engaging in litigation in a country with a less-developed IP system.
Life Sciences Intellectual Property Review (LSIPR) tracks the increasing challenges for intellectual property specialists in the rapidly evolving world of life sciences. From gene patents to stem cell research, we provide the very best news and analysis.
To continue reading this article and to access 4,500+ articles, our digital magazines and special reports published for LSIPR subscribers only then you will need a subscription.
If you are already subscribed please login.
Official LSIPR subscribers include:
Allen & Overy
Arnold & Siedsma
Birch, Stewart, Kolasch & Birch LLP (BSKB)
Carpmaels & Ransford
European Patent Office
George Washington Law School
Kirkland & Ellis International LLP
Marks & Clerk
NiKang Therapeutics Inc.
Powell Gilbert LLP
Procopio, Cory, Hargreaves & Savitch LLP
The United States Patent and Trademark Office (USPTO)
World Intellectual Property Office
For multi-user price options, or to check if your company has an existing subscription we can add you into for FREE, please contact Atif at firstname.lastname@example.org.
If you have any technical issues please email tech support.
Manisha Desai, Eli Lilly, patents, counsel, neuroscience, emerging markets, LSIPR 50 2018